FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nightti Long

Vanda Pharmaceuticals Inc.NASDAQ

Description

⋅ Dec 2, 2020 10:21 PM

VNDA: Vanda Pharmaceuticals Inc.
2020-12-01 18:22:00
FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome

Beyond Technical Analysis